Review article: Aminosalicylates for distal colitis

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue SUPPL. 3, 2006, Pages 41-44

  Gionchetti, P ^a,b   Rizzello, F ^a   Morselli, C ^a   Tambasco, R ^a   Campieri, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; MESALAZINE; PLACEBO; SALAZOSULFAPYRIDINE;

CLINICAL TRIAL; COLITIS; DESCENDING COLON; DOSE RESPONSE; DRUG EFFICACY; HUMAN; INFLAMMATION; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

AMINOSALICYLIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS; HUMANS;

EID: 33748325712     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03059.x     Document Type: Review

References (29)

1. Farrokh-Yar F, Swarbrick ET, Grace RH, et al. Excellent outcome of first attack of ulcerative colitis in three regional cohorts. Gastroenterology 1999; 116: A711.
2. Williams CN, Haber G, Aquino JA. Double-blind placebo-controlled evaluation of 5-ASA suppositories in active proctitis and measurement of extent of spread using 99m-Tc labelled 5-ASA suppositories. Dig Dis Sci 1987; 32: 71S-5S.
3. Jay M, Beihn RM, Digenis GA, et al. Disposition of radiolabelled suppositories in humans. J Pharm Pharmacol 1985; 37: 266-8.
4. Lucidarme D, Marteau P, Foucault M, et al. Efficacy and tolerance of mesalazine suppositories vs hydrocortisone foam in proctitis. Aliment Pharmacol Ther 1997; 11: 335-40.
5. Wilding IR, Kenyon CJ, Chauhan S, et al. Colonic spreading of a nonchlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitis. Aliment Pharmacol Ther 1995; 9: 161-6.
6. Van Bodegraven AA, Bower RO, Lourens J, et al. Distribution of mesalazine enemas in active and quiescent ulcerative colitis. Aliment Pharmacol Ther 1996; 10: 327-32.
7. Campieri M, Corbelli C, Gionchetti P, et al. Spread and distribution of 5-ASA colonic foam and 5-ASA enemas in patients with ulcerative colitis. Dig Dis Sci 1992; 37: 1890-7.
8. Gionchetti P, Venturi A, Rizzello F, et al. Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis. Aliment Pharmacol Ther 1997; 11: 679-84.
9. Campieri M, Paoluzi P, D'Albasio G, et al. Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicentre comparative trial with 5-ASA enema. Dig Dis Sci 1993; 38: 1843-50.
10. Gionchetti P, Ardizzone S, Benvenuti ME, et al. A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled trial. Aliment Pharmacol Ther 1999; 13: 381-8.
11. Marshall JK, Irvine EJ. Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther 1995; 9: 293-300.
12. Marshall JK, Irvine EJ. Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut 1997; 40: 775-81.
13. Cohen RD, Douglas M, Woseth BA, et al. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol 2000; 95: 1263-76.
14. Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatmentof ulcerative colitis. Ann Intern Med 1993; 118: 540-9.
15. Gionchetti P, Rizzello F, Venturi A, et al. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis. Dis Colon Rectum 1998; 41: 93-7.
16. Hebden JM, Blackshaw PE, Perkins AC, et al. Limited exposure of the healthy distal colon to orally-dosed formulation is further exaggerated in active left-sided ulcerative colitis. Aliment Pharmacol Ther 2000; 14: 155-61.
17. Safdi M, De Micco M, Sninsky C, et al. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Am J Gastroenterol 1997; 92: 1867-71.
18. Frieri G, Pimpo MT, Palombo GC, et al. Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs oral plus topical treatment. Aliment Pharmacol Ther 1999; 13: 1413-7.
19. Meucci G, Vecchi M, Astegiano M, et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Am J Gastroenterol 2000; 95: 469-73.
20. Langholz E, Munkholm P, Davidsen M, et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996; 31: 260-6.
21. Gionchetti P, Rizzello F, Venturi A, et al. Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis. Aliment Pharmacol Ther 1997; 11: 1053-7.
22. Marteau P, Florent C. Comparative, open, randomised trial of the efficacy and tolerance of slow-release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis: French Pentasa Study Group. Am J Gastroenterol 2000; 95: 166-70.
23. Campieri M, Gionchetti P, Belluzzi A, et al. 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? J Clin Gastroenterol 1988; 10: 663-8.
24. Reddy SI, Friedman S, Telford JJ, et al. Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol 2005; 100: 1357-61.
25. Marshall JK, Irvine EJ. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Am J Gastroenterol 2000; 95: 1628-36.
26. Marteau P, Crand J, Foucault M, Rambaud JC. Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study. Gut 1998; 42: 195-9.
27. Sutherland L, Roth D, Beck P, et al. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis (Cochrane Review). Cochrane Database Syst Rev 2002; 4: CD000544.
28. D'Albasio G, Pacini F, Camarri E, et al. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. Am J Gastroenterol 1997; 92: 1143-7.
29. Frieri G, Pimpo MT, Galletti B, et al. Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis. Dig Liver Dis 2005; 37: 92-6.